Microsatellite alterations in plasma DNA of primary breast cancer patients

Clinical Cancer Research

Volumn 6, Issue 3, 2000, Pages 1119-1124

  Shaw, Jacqueline A ^a   Smith, Brendan M ^b   Walsh, Tom ^c   Johnson, Suzanne ^a   Primrose, Lindsay ^a   Slade, Martin J ^b   Walker, Rosemary A ^a   Coombes, R Charles ^b  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKERATIN 19; MICROSATELLITE DNA;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER SCREENING; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; FEMALE; HETEROZYGOSITY LOSS; HUMAN; IMMUNOCYTOCHEMISTRY; MAJOR CLINICAL STUDY; MICROSATELLITE INSTABILITY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; ALLELES; BONE MARROW; BREAST NEOPLASMS; DNA, NEOPLASM; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KERATINS; LOSS OF HETEROZYGOSITY; LYMPHOCYTES; MICROSATELLITE REPEATS; MIDDLE AGED; NEOPLASM METASTASIS; RNA, MESSENGER;

EID: 0034016961     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Mulchahy, H. E., Croke, D. T., and Farthing, M. J. G. Cancer and mutant DNA in blood plasma. Lancet, 348: 628, 1996.
2. Shapiro, B., Chakrabarty, M., Cohn, E. M., and Leon, S. A. Determination of circulating DNA levels in patients with benign or malignant gastrointestinal disease. Cancer (Phila.), 51: 2116-2120, 1983.
3. Koffler, D., Agnello, V., Winchester, R., and Kunkel, H. The occurrence of single stranded DNA in the serum of patients with SLE and other diseases. J. Clin. Investig., 52: 198-204, 1973.
4. Davis, G. L., and Davis, J. S. Detection of circulating DNA by counter immunoelectrophoresis (CIE). Arthritis Rheum., 16: 52-58, 1973.
5. Leon, S. A., Revach, M., Ehrlich, G. E., Adler, R., Petersen, V., and Shapiro, B. DNA in synovial fluid and the circulation of patients with arthritis. Arthritis Rheum., 24: 1142-1150, 1981.
6. Leon, S. A., Shapiro, B., Sklaroff, D. M., and Yaros, M. J. Free DMA in the serum of cancer patients and the effect of therapy. Cancer Res., 37: 646-650, 1977.
7. Stroun, M., Anker, P., Lyautey, J., Lederrey, C., and Maurice, P. A. Isolation and characterization of DKA from the plasma of cancer patients. Eur. J. Cancer Clin. Oncol., 28: 707-712, 1987.
8. Maebo, A. Plasma DNA level as a tumour marker in primary lung cancer. Jpn. J. Thorac. Dis., 28: 1085-1091, 1990.
9. Chen, X. Q., Stroun, M., Magnenat, J. L., Nicod, L. P., Kurt, A. M., Lyautey, J., Lederrey, C., and Anker, P. Microsatellite alterations in plasma DNA of small cell lung cancer patients. Nat. Med., 2: 1033-1035, 1996.
10. Nawroz, H., Koch, W., Anker, P., Stroun, M., and Sidransky, D. Microsatellite alterations in serum DNA of head and neck patients. Nat. Med., 2: 1035-1037, 1996.
11. Silva, J. M., Dominhuez, G., Garcia, J. M., Gonzalez, R., Villanueva, M. J., Navarro, F., Provencio, M., San Martin, S., Espana, P., and Bonilla, F. Presence of tumour DNA in plasma of breast cancer patients: clinicopathological correlations. Cancer Res., 59: 3251-3256, 1999.
12. Chen, X., Bonnefoi, H., Diebold-Berger, S., Lyautey, J., Lederrey, C., Faltin-Traube, E., Stroun, M., and Anker, P. Detecting tumor-related alterations in plasma or serum DNA of patients diagnosed with breast cancer. Clin. Cancer Res., 5: 2297-2303, 1999.
13. Shaw, J. A., Walsh, T., Chappell, S., Carey, N., Johnson, K., and Walker, R. A. Microsatellite instability in early sporadic breast cancer. Br. J. Cancer, 73: 1393-1397, 1996.
14. Chappell, S. A., Walsh, T., Walker, R. A., and Shaw, J. A. Loss of heterozygosity at chromosome 6q in pre-invasive and early invasive breast carcinomas. Br. J. Cancer, 75: 1324-1329, 1997.
15. Walsh, T., Chappell, S. A., Shaw, J. A., and Walker, R. A. Microsatellite instability in ductal carcinoma in situ of the breast. J. Pathol., 185: 18-24, 1998.
16. Lo, Y. M. D., Corbetta, N., Chamberlain, P. F., Rai, V., Sargent, I. L., and Redman, C. W. G. Presence of fetal DNA in maternal plasma and serum. Lancet, 350: 485-487, 1997.
17. Brook, J. D., McCurrach, M. E., Harley, H. G., Buckler, A. J., Church, D., Aburatani, H., Hunter, K., Stanton, V. P., Thirion, J. P., Hudson, T., Sohn, R., Zemelman, B., Snell, R. G., Rundle, S. A., Crow, S., Davies, J., Shelbourne, P., Buxton, J., Jones, C., Juvonen, V., Johnson, K., Harper, P. S., Shaw, D. J., and Houseman, D. E. Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3′ end of a transcript encoding a protein kinase family member. Cell, 68: 799-808, 1992.
18. Weissenbach, J., Gyapay, G., Dib, C., Vignal, A., Morisette, J., Millasseau, P., Vaysseix, G., and Lathrop, M. A second generation linkage map of the human genome. Nature (Lond.), 359: 794-801, 1992.
19. Cross, N. C. P., Feng, L., Chase, A., Bungey, J., Hughes, T. P., and Goldman, J. M. Competitive polymerase chain reaction to estimate the number of BCR-ABL transcripts in chronic myeloid leukemia patients after bone marrow transplantation. Blood, 82: 1923-1936, 1993.
20. Slade, M. J., Smith, B. M., and Coombes, R. C. QPCR for the detection of micrometastasis in breast cancer. J. Clin. Oncol., 17: 870-879, 1999.
21. Hochtlen-Vollmar, W., Gruber, R., Bodenmuller, H., Felber, E., Lindemann, F., Passlick, B., Schlimok, G., Pantel, K., and Reithmuller, G. Occult epithelial tumour cells detected in bone marrow by an enzyme immunoassay specific for cytokeratin 19. Int. J. Cancer, 70: 396-400, 1997.
22. Anker, P., Lefort, F., Vasioukhin, V., Lyautry, J., Lederrey, C., Chen, X. Q., Stroun, M., Mulcahy, H. E., and Farthing, M. J. G. K-ras point mutations are found in DNA extracted from the plasma of patients with colorectal cancer. Gastroenterology, 112: 1114-1120, 1997.
23. Redding, W. H., Coombes, R. C., Monaghan, P., Clink, H. M. D., Imrie, S. F., Dearnaley, D. P., Ormerod, M. G., Sloane, J. P., Gazet, J-C., Powles, T. J., and Neville, A. M. Detection of micrometastases in patients with primary breast cancer. Lancet, 2: 1271-1273, 1983.
24. Iida, A., Isobe, R., Yoshimoto, M., Kasumi, F., Nakamura, Y., and Emi, M. Localization of a breast cancer tumour-suppressor gene to a 3-cM interval within chromosomal region 16q22. Br. J. Cancer, 75: 264-267, 1997.
25. Wooster, R., Clenton-Jansen, A. M., Collins, N., Mangion, J., Cornelis, R. S., Cooper, C. S., Gusterson, B. A., Ponder, B. A. J., Von Deimling, A., Weistler, O. D., Cornelisse, C. J., Devilee, P., and Stratton, M. R. Instability of short tandem repeats (microsatellites) in human cancers. Nat. Genet., 6: 152-156, 1994.
26. Sidransky, D., Tokino, T., Hamilton, S. R., Kinzler K. W., Levin, B., Frost, P., and Vogelstein, B. Identification of ras oncogene mutations in the stool of patients with curable colorectal tumours. Science (Washington DC), 256; 102-105, 1992.
27. Eguchi, S., Kohara, N., Komatu, K., and Kanematsu, T. Mutations of the p53 gene in the stool of patients with resectable colorectal cancer. Cancer (Phila.), 77: 1707-1710, 1996.
28. Kopreski, M. S., Benko, F. A., Kwee, C., Leitzel, K. E., Eskander, E., Lipton, A., and Gocke, C. D. Detection of mutant K-ras DNA in plasma or serum of patients with colorectal cancer. Br. J. Cancer, 76: 1293-1299, 1997.